Innovation Pharmaceuticals Inc (IPIX)

[Whoops]

I see Google finance updated the company description on their website.

Description
Cellceutix Corporation (Cellceutix) is a clinical-stage biotechnology company focused on discovering small molecule drugs for diseases, including drug-resistant cancers, psoriasis, autism and inflammatory disease. The Company is focused on developing therapies in oncology, dermatology and antibiotic applications. The Company is also developing pre-clinical compounds for the treatment of diseases, including rheumatoid arthritis, asthma, Lou Gehrig Disease, Parkinson’s disease and multiple sclerosis. The Company’s lead cancer compound, Kevetrin, and other oncology compound is Brilacidin-OM. Prurisol is Cellceutix’s anti-psoriasis drug candidate. Cellceutix’s lead antibiotic compound, Brilacidin, is used for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The Company’s product KM 391 is an Autism compound. The Company’s other pre-clinical candidates include KM 277, KM 278, KM 362, KM-3174 and KM-732.
https://www.google.com/finance?q=OTCMKTS%3ACTIX&ei=KEvAVeHUA4OBiwLnhraoBg

Not many small 300 million biotechs have such a "robust" description.